Effects of Recombinant Human Glutamic Acid Decarboxylase . . . - Related Studies

Effects of Recombinant Human Glutamic Acid Decarboxylase . . .

This study is not yet open for participant recruitment.

Study NCT00529399. Last updated on August 20, 2008. Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Type 1 Diabetes Mellitus

2	Additional conditions recognized in this trial
		Diabetes Mellitus
		Diabetes Mellitus, Type 1

3	More general conditions related to this trial
		Autoimmune Diseases
		Endocrine System Diseases
		Glucose Metabolism Disorders
		Immune System Diseases
		Metabolic Diseases

4	Interventions listed in this trial
		GAD-Alum
		Aluminum hydroxide

5	Additional drug interventions recognized in this trial
		Aluminum sulfate

6	More general drug interventions related to this trial
		Adjuvants, Immunologic
		Antacids
		Immunologic Factors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
		Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
		National Institute of Allergy and Infectious Diseases (NIAID)
		National Center for Research Resources (NCRR)
		American Diabetes Association
		Juvenile Diabetes Research Foundation